Page last updated: 2024-10-24

negative regulation of CD8-positive, alpha-beta T cell activation

Definition

Target type: biologicalprocess

Any process that stops, prevents or reduces the frequency, rate or extent of CD8-positive, alpha-beta T cell activation. [GOC:obol]

Negative regulation of CD8-positive, alpha-beta T cell activation is a crucial process in maintaining immune homeostasis and preventing autoimmunity. It involves a complex interplay of signaling pathways and regulatory mechanisms that suppress the activation of CD8+ T cells, which are essential for recognizing and eliminating virally infected cells and tumor cells.

CD8+ T cell activation is initiated by the recognition of antigen presented by major histocompatibility complex (MHC) class I molecules on antigen-presenting cells (APCs), such as dendritic cells. This interaction triggers a cascade of signaling events, leading to the production of cytokines, cell proliferation, and differentiation into effector T cells.

However, uncontrolled activation of CD8+ T cells can result in autoimmune diseases, where the immune system mistakenly attacks healthy cells. Therefore, negative regulation of CD8+ T cell activation is essential for maintaining tolerance to self-antigens and preventing these harmful responses.

Several mechanisms contribute to the negative regulation of CD8+ T cell activation:

1. **Inhibitory Receptors:** CD8+ T cells express inhibitory receptors, such as CTLA-4 and PD-1, which bind to ligands on APCs. These interactions deliver inhibitory signals that dampen T cell activation by interfering with downstream signaling pathways.

2. **Regulatory T Cells (Tregs):** Tregs are a specialized subset of T cells that suppress the activation of other T cells, including CD8+ T cells. They express the transcription factor Foxp3, which is essential for their suppressive function. Tregs can suppress CD8+ T cell activation through various mechanisms, including production of inhibitory cytokines like IL-10 and TGF-β, and by directly interacting with CD8+ T cells.

3. **Cytokine Signaling:** Certain cytokines, such as IL-10 and TGF-β, have an inhibitory effect on CD8+ T cell activation. These cytokines can suppress T cell proliferation, cytokine production, and effector function.

4. **Apoptosis:** In some cases, CD8+ T cells may undergo apoptosis, or programmed cell death, as a mechanism to prevent excessive activation and potential autoimmune damage.

5. **Metabolic Regulation:** The metabolic state of CD8+ T cells influences their activation and function. Negative regulators can influence metabolic pathways, limiting the availability of resources needed for full activation.

6. **Microenvironment:** The local environment within tissues can also influence the activation of CD8+ T cells. Factors like the presence of other immune cells, chemokines, and matrix proteins can contribute to the regulation of T cell activation.

Overall, the negative regulation of CD8+ T cell activation is a complex process involving multiple levels of control. These mechanisms ensure that the immune response is appropriately tailored to the specific threat, preventing excessive inflammation and maintaining immune tolerance. '
"

Proteins (1)

ProteinDefinitionTaxonomy
Programmed cell death 1 ligand 1A programmed cell death 1 ligand 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q9NZQ7]Homo sapiens (human)

Compounds (4)

CompoundDefinitionClassesRoles
sesamin(+)-sesamin : A lignan that consists of tetrahydro-1H,3H-furo[3,4-c]furan substituted by 1,3-benzodioxole groups at positions 1 and 4 (the 1S,3aR,4S,6aR stereoisomer). Isolated from Cinnamomum camphora, it exhibits cytotoxic activity.benzodioxoles;
furofuran;
lignan
antineoplastic agent;
neuroprotective agent;
plant metabolite
pomalidomide3-aminophthalimidoglutarimide: structure in first sourcearomatic amine;
dicarboximide;
isoindoles;
piperidones
angiogenesis inhibitor;
antineoplastic agent;
immunomodulator
apiinapiin : A beta-D-glucoside having a beta-D-apiosyl residue at the 2-position and a 5,4'-dihydroxyflavon-7-yl moiety at the anomeric position.

apiin: structure
beta-D-glucoside;
dihydroxyflavone;
glycosyloxyflavone
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
plant metabolite
fosbretabulinstilbenoid